Voriconazole

Sold as Vfend, Vfend iv, Aviconal, Voriconazole accord, Rextro, Vondip iv, Vorispore iv, Vcide iv, Vcide fc, Vorifend iv, Vicomyl iv, Glezole, Voriconazole inj hetero, Vosaric, Hetevori, Immavor, Immanaz, Voriconazole fresenius

C₁₆H₁₄F₃N₅O349.31 g/mol

(2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol

Drag to rotate. Structure from PubChem CID 71616.

Loading Wikipedia summary

Registration

Applicants: 12
Registrations: 23
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Pfizer Laboratories (Pty) Ltd	Vfend, Vfend iv	50 mg, 200 mg	360106, 360107, 360108	S4	None
Accord Healthcare (Pty) Ltd	Aviconal, Voriconazole accord	50, 200	480154, 480155, 480156	S4	None
Dr Reddyæs Laboratories (Pty) LtdCancelled	Rextro	50, 200	480503, 480504	S4	None
Pharma Dynamics (Pty) Ltd	Vondip iv	200 mg	490472	S4	PI PIL
Astral Pharma (Pty) Ltd	Vorispore iv	200 mg	491210	S4	PI PIL
Macleods Pharmaceuticals SA (Pty) LtdCertificate held by Abex (Pty) Ltd	Vcide iv, Vcide fc	50, 200mg	491211, 500786, 500787	S4	PI PIL
Activo Health (Pty) Ltd	Vorifend iv	Not stated	520021	S4	None
Oethmaan Biosims (Pty) LtdCertificate held by Viatris south africa	Vicomyl iv	200 mg	520993	S4	PI PIL
Glenmark Pharmaceuticals South Africa (Pty) Ltd	Glezole	50 mg, 200 mg	530148, 530149	S4	None
Hetero Drugs South Africa (Pty) Ltd	Voriconazole inj hetero, Vosaric, Hetevori	Not stated	540292, 540293.292, 540294.292	S4	None
Ruby Pharmaceuticals (Pty) Ltd	Immavor, Immanaz	200 mg	550782, 550783.782	S4	PI PIL
Fresenius Kabi South Africa (Pty) Ltd	Voriconazole fresenius	200 mg	561130	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Vfend 50 MG EACH TABLET CONTAINS VORICONAZOLE 50,0 mg	50 mg	36010636/20.1.7/0106	Registered	S4	None
Vfend 200 MG EACH TABLET CONTAINS VORICONAZOLE 200,0 mg	200 mg	36010736/20.1.7/0107	Registered	S4	None
Vfend iv 200 MG EACH 20,0 ml SOLUTION CONTAINS VORICONAZOLE 200,0 mg	200 mg	36010836/20.1.7/0108	Registered	S4	None
Aviconal 200 EACH TABLET CONTAINS VORICONAZOLE 200,0 mg	200	48015448/20.1.7/0154	Registered	S4	None
Voriconazole 50 accord EACH TABLET CONTAINS VORICONAZOLE 50,0 mg	50	48015548/20.1.7/0155	Registered	S4	None
Voriconazole 200 accord EACH TABLET CONTAINS VORICONAZOLE 200,0 mg	200	48015648/20.1.7/0156	Registered	S4	None
Rextro 50 EACH TABLET CONTAINS: VORICONAZOLE 50,0 mg	50	48050348/20.1.7/0503	Cancelled	S4	None
Rextro 200 EACH TABLET CONTAINS: VORICONAZOLE 200,0 mg	200	48050448/20.1.7/0504	Cancelled	S4	None
Vondip iv	200 mg.Powder for solution for infusion.	49047249/20.1.7/0472Approved 10 March 2025	Registered	S4	PI PIL
Vorispore 200 iv	200 mgPowder for solution for infusion	49121049/20.1.7/1210Approved 30 June 2021	Registered	S4	PI PIL
Vcide 200 iv	200mgPowder for solution for infusion	49121149/20.1.7/1211Approved 21 January 2021	Registered	S4	PI PIL
Vcide 50 fc Each Tablet contains: Voriconazole 50 mg	50	50078650/20.1.7/0786	Registered	S4	None
Vcide 200 fc Each Tablet contains: Voriconazole 200 mg	200	50078750/20.1.7/0787	Registered	S4	None
Vorifend iv EACH VIAL CONTAINS: VORICONAZOLE 200,0 mg	Not listed	52002152/20.1.7/0021	Registered	S4	None
Vicomyl 200 MG iv EACH VIAL CONTAINS: VORICONAZOLE 200,0 mg	200 mgPowder for solution for infusion.	52099352/20.1.1/0993Approved 6 November 2023	Registered	S4	PI PIL
Glezole 50 MG EACH TABLET CONTAINS VORICONAZOLE 50 mg	50 mg	53014853/20.2.2/0148	Registered	S4	None
Glezole 200 MG EACH TABLET CONTAINS VORICONAZOLE 50 mg	200 mg	53014953/20.2.2/0149	Registered	S4	None
Voriconazole inj hetero EACH VIAL CONTAINS VORICONAZOLE 200,0 mg	Not listed	54029254/20.1.7/0292	Registered	S4	None
Vosaric EACH VIAL CONTAINS VORICONAZOLE 200,0 mg	Not listed	540293.29254/20.1.7/0293.292	Registered	S4	None
Hetevori EACH VIAL CONTAINS VORICONAZOLE 200,0 mg	Not listed	540294.29254/201.7/0294.292	Registered	S4	None
Immavor VORICONAZOLE	200 mgPowder for solution for injection	55078255/20.1.7/0782Approved 14 February 2023	Registered	S4	PI PIL
Immanaz VORICONAZOLE	200 mgPowder for solution for injection	550783.78255/20.1.7/0783.782Approved 14 February 2023	Registered	S4	PI PIL
Voriconazole 200 MG fresenius EACH VIAL CONTAINS VORICONAZOLE 200,0 mg	200 mg	56113056/20.1.7/1130	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Voriconazole

S4: Voriconazole
Consolidated Schedules 06 July 2026, line 8396

Pharmacological class: Antifungal antibiotics. (class 20.1.7)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Vondip iv, Pharma Dynamics (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsVondip iv, Pharma Dynamics (Pty) Ltd Patient information leaflet (PIL)For patients and carersVondip iv, Pharma Dynamics (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background